colonic FTRD Set (200.70); diagnostic FTRD Set (200.76); gastroduodenal FTRD Set (200.72)
Ovesco Endoscopy AG · Decision date Sep 14, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 14, 2026 for Ovesco Endoscopy AG's premarket notification K253481, received October 14, 2025. The notification covers three device sets: colonic FTRD Set (200.70), diagnostic FTRD Set (200.76) and gastroduodenal FTRD Set (200.72). The public record lists the classification name as Hemostatic Metal Clip For The GI Tract, regulation number 876.4400, primary product code PKL and subsequent product codes FDI, KNS and OCZ, with Gastroenterology/Urology as the review panel and medical specialty. The FDA letter describes the subject device as an over-the-scope clip application device used within flexible endoscopy in the gastrointestinal tract.
SESE means the notification was cleared for marketing; it is not a PMA approval. The record identifies the submission as a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan. Novineon CRO GmbH is listed as correspondent, with Maria Kiel as correspondent contact and applicant contact Antonio Caputo. The available excerpts do not state which predicates were cited, what testing supported equivalence, or any indications, contraindications or clinical performance results; those details would sit in the underlying summary document, which is not reproduced here.
The record also does not describe differences among the three set variants or any changes relative to previously cleared versions. Readers should treat the clearance as covering the named sets as submitted, without inferring comparative performance or expanded labeling beyond what the FDA documents state.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Sep 14, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K253481
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Ovesco Endoscopy AG
- Product code
- PKL
- Decision code
- SESE
- Decision date
- Sep 14, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Hemostatic Metal Clip For The Gi Tract.
- Applicant
- Ovesco Endoscopy AG
- Product code
- PKL
- FDA device class
- 2
FDA decision timeline
K253481 received
Application receipt date recorded by FDA.
K253481 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code PKL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Ovesco Endoscopy AG | 510(k) clearance | Oct 2, 2026 | FDA | |
Hemostatic ClipK261741 | Anrei Medical (Hz) Co., Ltd. | 510(k) clearance | Oct 2, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Ovesco Endoscopy AG
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Tuebingen
Sources and methodology
- Original FDA record: K253481
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
